Insulin is a 51-amino acid peptide hormone composed of two polypeptide chains (A-chain and B-chain) linked by disulfide bonds. It is synthesized as preproinsulin in pancreatic beta cells, processed through the secretory pathway to generate mature insulin, and secreted into the extracellular space in response to elevated blood glucose. The primary core function of insulin is regulation of glucose homeostasis through binding to the insulin receptor, triggering intracellular signaling cascades (primarily PI3K/AKT and MAPK pathways) that stimulate glucose uptake in muscle and adipose tissue, suppress hepatic glucose production, promote glycogen synthesis, stimulate lipogenesis, and inhibit lipolysis and protein degradation. Beyond its metabolic roles, insulin has important functions in cell growth, proliferation, and neuroprotection.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0005158 insulin receptor binding | IBA GO_REF:0000033 | ACCEPT | Summary: This annotation represents the core molecular function of insulin - specific binding to the insulin receptor. The deep research extensively documents insulin-receptor interactions, including the two-site binding model with site-1 (high affinity, Kd ~10-30 nM) formed by L1 domain and Ξ±CT domain, and site-2 (lower affinity). Structural studies have revealed the stepwise activation mechanism involving conformational transitions from Ξ-shaped to Ξ-shaped to T-shaped receptor states upon insulin binding. Reason: This is the primary and most specific molecular function term for insulin. The IBA evidence is well-supported by extensive structural and biochemical data showing insulin's high-affinity and specific binding to the insulin receptor. This annotation accurately captures the core molecular activity of the protein. Supporting Evidence: file:human/INS/INS-deep-research-perplexity.md Insulin binding to site-1, the primary insulin-binding site, is composed of the L1 domain of one Ξ±-subunit and the Ξ±CT domain of the adjacent Ξ±-subunit; insulin binds to this site with high affinity (Kd approximately 10-30 nanomolar) file:human/INS/INS-deep-research-perplexity.md The binding of insulin to its extracellular receptor leads to rapid and sequential autophosphorylation of multiple tyrosine residues distributed across different domains of the intracellular region file:human/INS/INS-deep-research-falcon.md Insulin acts mainly by binding **INSR**, which autophosphorylates and recruits adaptor proteins (IRS, Shc), bifurcating into |
| GO:0005179 hormone activity | IBA GO_REF:0000033 | ACCEPT | Summary: Insulin functions as a peptide hormone secreted by pancreatic beta cells that acts systemically to regulate metabolism. This annotation correctly captures insulin's role as a signaling molecule that travels through the bloodstream to affect distant target tissues. Reason: This is an accurate but general annotation. While "insulin receptor binding" is more specific and informative, "hormone activity" is also correct and provides appropriate high-level classification of insulin's molecular function. Both terms are valid and complementary. Supporting Evidence: file:human/INS/INS-deep-research-perplexity.md Insulin functions as a 51-amino acid peptide hormone composed of two polypeptide chains linked by disulfide bonds, with the primary physiological role of regulating blood glucose homeostasis through complex signaling cascades PMID:38397072 Insulin is a polypeptide hormone synthesized and secreted by pancreatic Ξ²-cells. It plays an important role as a metabolic hormone. |
| GO:0005615 extracellular space | IBA GO_REF:0000033 | ACCEPT | Summary: Insulin is secreted from pancreatic beta cells and functions in the extracellular space, where it travels through the bloodstream to reach target tissues. This is the primary location where mature insulin carries out its function as a hormone. Reason: This is the correct and most specific cellular component annotation for the location where mature insulin functions. Insulin is a secreted hormone that acts in the extracellular space. The IBA annotation is well-supported and represents the core functional location. Supporting Evidence: file:human/INS/INS-uniprot.txt SUBCELLULAR LOCATION: Secreted. file:human/INS/INS-deep-research-perplexity.md Insulin is secreted from pancreatic beta cells into the extracellular space in response to elevated blood glucose file:human/INS/INS-deep-research-falcon.md **Plasma membrane/extracellular:** Ca2+-triggered exocytosis releases insulin to circulation; insulin acts as a ligand for the insulin receptor in peripheral tissues. |
| GO:0050714 positive regulation of protein secretion | IBA GO_REF:0000033 | KEEP AS NON CORE | Summary: This annotation likely refers to insulin's effects on stimulating secretion of various proteins in target tissues, or possibly feedback effects on beta cell secretory processes. Reason: While insulin may have some effects on protein secretion in various tissues, this is not a primary or well-characterized core function of insulin. The primary functions are glucose homeostasis, metabolic regulation, and cell growth. This annotation represents a more peripheral effect and should be marked as non-core. |
| GO:0042593 glucose homeostasis | IBA GO_REF:0000033 | ACCEPT | Summary: This is THE core biological process for insulin. Insulin's primary physiological role is maintaining blood glucose homeostasis through stimulation of glucose uptake, suppression of hepatic glucose production, and coordination of glucose storage as glycogen. Reason: This annotation captures the central and most important biological function of insulin. Extensive literature documents insulin's critical role in glucose homeostasis, and this is the primary reason insulin exists as a hormone. This is a core annotation that must be retained. Supporting Evidence: file:human/INS/INS-deep-research-perplexity.md The most physiologically important function of insulin is the stimulation of glucose uptake from the bloodstream into insulin-responsive tissues, particularly skeletal muscle and adipose tissue file:human/INS/INS-deep-research-perplexity.md Insulin potently suppresses hepatic glucose production through both direct actions on the liver and indirect actions mediated by effects on adipose tissue, muscle, and central nervous system signaling file:human/INS/INS-uniprot.txt Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. PMID:38397072 Insulin influences the metabolism of glucose, regulating plasma glucose levels and stimulating glucose storage in organs such as the liver, muscles and adipose tissue. file:human/INS/INS-deep-research-falcon.md Human **INS (P01308)** encodes a secreted peptide hormone precursor whose primary function is to produce **mature insulin** (A/B chains) that is stored in dense-core secretory granules and released in a **glucose- and Ca2+-regulated** manner from Ξ²-cells to maintain systemic metabolic homeostasis. |
| GO:0005179 hormone activity | IEA GO_REF:0000120 | ACCEPT | Summary: Duplicate of IBA annotation above. Electronic annotation based on InterPro domains and keywords. Reason: This is a duplicate annotation (same term as line 2) but with different evidence code (IEA vs IBA). Both are correct. Duplicates are acceptable as they come from different evidence pipelines. |
| GO:0005576 extracellular region | IEA GO_REF:0000120 | ACCEPT | Summary: This is a more general parent term of "extracellular space" (GO:0005615). Both are correct but extracellular space is more specific. Reason: While "extracellular space" is more specific and preferred, this annotation is not wrong. It's a valid broader term. Having both the specific and general terms is acceptable in GO annotation practice. |
| GO:0006006 glucose metabolic process | IEA GO_REF:0000043 | ACCEPT | Summary: Insulin regulates glucose metabolism broadly, including glucose uptake, glycolysis, glycogen synthesis, and suppression of gluconeogenesis. This is a valid but broad term. Reason: This is an accurate but general term. "Glucose homeostasis" is more specific to insulin's regulatory role, but "glucose metabolic process" is also correct as insulin affects multiple aspects of glucose metabolism. Both terms provide useful information at different levels of specificity. Supporting Evidence: file:human/INS/INS-deep-research-perplexity.md Once inside the cell, glucose is phosphorylated by hexokinase to glucose-6-phosphate, which is then retained in the cell and utilized for glycolysis or stored as glycogen file:human/INS/INS-uniprot.txt It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. |
| GO:1901701 cellular response to oxygen-containing compound | IEA GO_REF:0000117 | MARK AS OVER ANNOTATED | Summary: This is an extremely broad term that could apply to almost any cellular process. Insulin may technically be involved in responses to various oxygen-containing compounds, but this annotation is not informative about insulin's specific function. Reason: This term is far too general and non-specific to be useful for insulin annotation. While technically insulin signaling may involve responses to oxygen-containing compounds, this annotation doesn't capture any meaningful aspect of insulin's specific biological role. This represents computational over-annotation from ARBA. |
| GO:0005515 protein binding | IPI PMID:17051221 Structures of human insulin-degrading enzyme reveal a new su... | MODIFY | Summary: This annotation is based on physical interaction with insulin-degrading enzyme (IDE). While technically correct, "protein binding" is uninformative. The more specific term "protease binding" is annotated separately for this interaction. Reason: Generic "protein binding" annotations should be replaced with more specific binding terms when available. In this case, since insulin binds to IDE (a protease), the annotation "protease binding" (GO:0002020) already exists and is more informative. However, the primary binding partner is the insulin receptor, so "insulin receptor binding" is most important. Proposed replacements: protease binding Supporting Evidence: PMID:17051221 Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. |
| GO:0005515 protein binding | IPI PMID:23302862 How insulin engages its primary binding site on the insulin ... | MODIFY | Summary: This annotation is based on interaction with insulin receptor (INSR). This is the most important molecular interaction for insulin, but "protein binding" is too general. Reason: This interaction with insulin receptor should be annotated with the specific term "insulin receptor binding" (GO:0005158) which already exists in the annotation set, rather than the generic "protein binding" term. Proposed replacements: insulin receptor binding Supporting Evidence: PMID:23302862 How insulin engages its primary binding site on the insulin receptor. |
| GO:0005515 protein binding | IPI PMID:29512653 Structure of the insulin receptor-insulin complex by single-... | MODIFY | Summary: This is another annotation for insulin-insulin receptor interaction based on cryo-EM structure determination. Same issue as above - too generic. Reason: Should use "insulin receptor binding" (GO:0005158) instead of generic "protein binding". Proposed replacements: insulin receptor binding Supporting Evidence: PMID:29512653 Structure of the insulin receptor-insulin complex by single-particle cryo-EM analysis. |
| GO:0005515 protein binding | IPI PMID:32296183 A reference map of the human binary protein interactome. | ACCEPT | Summary: This is from a large-scale binary protein interactome study. Multiple different binding partners detected, but all use generic "protein binding" term. Reason: For high-throughput interactome studies where specific binding functions haven't been characterized, "protein binding" is acceptable. These annotations document physical interactions even if more specific functional terms aren't yet available. Supporting Evidence: PMID:32296183 Apr 8. A reference map of the human binary protein interactome. |
| GO:0005515 protein binding | IPI PMID:9388210 Inhibition of insulin receptor activation by insulin-like gr... | ACCEPT | Summary: Interaction with insulin-like growth factor binding proteins (IGFBPs) that can inhibit insulin receptor activation. Reason: Without a more specific term for IGFBP binding available in GO, "protein binding" is acceptable for documenting this interaction. This interaction has functional significance for insulin receptor signaling. Supporting Evidence: PMID:9388210 Inhibition of insulin receptor activation by insulin-like growth factor binding proteins. |
| GO:0005515 protein binding | IPI PMID:9773776 Megalin is an endocytic receptor for insulin. | ACCEPT | Summary: Interaction with megalin, an endocytic receptor that can internalize insulin. Reason: This documents a specific interaction with megalin that is relevant for insulin clearance and degradation. Without a more specific GO term available, "protein binding" is acceptable. Supporting Evidence: PMID:9773776 Megalin is an endocytic receptor for insulin. |
| GO:0042802 identical protein binding | IPI PMID:10508408 Structural consequences of the B5 histidine --> tyrosine mut... | ACCEPT | Summary: This and the following 7 annotations document insulin's ability to form dimers and higher-order oligomers (hexamers). This is important for insulin storage in secretory granules as zinc-insulin hexamers. Reason: Insulin oligomerization is a well-established and functionally important property. Insulin forms dimers and zinc-stabilized hexamers that are the storage form in pancreatic beta cells. Multiple independent studies support this annotation. Supporting Evidence: file:human/INS/INS-deep-research-perplexity.md Insulin possesses a histidine residue at position B10 that coordinates zinc ions, enabling the formation of zinc-stabilized hexamers through a toroidal geometry in which two zinc ions coordinate the B10 histidine residues of three insulin dimers file:human/INS/INS-deep-research-perplexity.md These zinc-insulin hexamers represent the predominant storage form of insulin within pancreatic beta cell secretory granules PMID:10508408 Structural consequences of the B5 histidine --> tyrosine mutation in human insulin characterized by X-ray crystallography and conformational analysis. |
| GO:0042802 identical protein binding | IPI PMID:17472440 A helical structural nucleus is the primary elongating unit ... | ACCEPT | Summary: Study on insulin amyloid fibril formation, another form of insulin self-association. Reason: While amyloid formation is pathological rather than physiological, it does represent insulin-insulin binding. The annotation is technically correct. Supporting Evidence: PMID:17472440 A helical structural nucleus is the primary elongating unit of insulin amyloid fibrils. |
| GO:0042802 identical protein binding | IPI PMID:20738396 Structural features of proinsulin C-peptide oligomeric and a... | ACCEPT | Summary: Structural study of proinsulin C-peptide oligomerization. Note this is about C-peptide, not mature insulin. Reason: C-peptide is part of the proinsulin precursor, and this annotation applies to the full-length preproinsulin/proinsulin forms that are present during biosynthesis. Supporting Evidence: PMID:20738396 2010 Aug 3. Structural features of proinsulin C-peptide oligomeric and amyloid states. |
| GO:0042802 identical protein binding | IPI PMID:22854022 SERF protein is a direct modifier of amyloid fiber assembly. | ACCEPT | Summary: Study on SERF protein as modifier of amyloid fiber assembly involving insulin. Reason: Documents insulin self-association in context of amyloid formation. Supporting Evidence: PMID:22854022 2012 Jul 26. SERF protein is a direct modifier of amyloid fiber assembly. |
| GO:0042802 identical protein binding | IPI PMID:23106816 Insulin solubility transitions by pH-dependent interactions ... | ACCEPT | Summary: Study on insulin solubility transitions involving interactions with C-peptide. Reason: Documents insulin oligomerization behavior. Supporting Evidence: PMID:23106816 Insulin solubility transitions by pH-dependent interactions with proinsulin C-peptide. |
| GO:0042802 identical protein binding | IPI PMID:23416304 Amino acid sequence determinants in self-assembly of insulin... | ACCEPT | Summary: Study on amino acid determinants in insulin amyloid superstructures. Reason: Documents insulin self-assembly properties. Supporting Evidence: PMID:23416304 2013 Feb 14. Amino acid sequence determinants in self-assembly of insulin chiral amyloid superstructures: role of C-terminus of B-chain in association of fibrils. |
| GO:0042802 identical protein binding | IPI PMID:23510797 Peptides that form Ξ²-sheets on hydrophobic surfaces accelera... | ACCEPT | Summary: Study on surface-induced insulin amyloidal aggregation. Reason: Documents insulin oligomerization. Supporting Evidence: PMID:23510797 2013 Mar 16. Peptides that form Ξ²-sheets on hydrophobic surfaces accelerate surface-induced insulin amyloidal aggregation. |
| GO:0042802 identical protein binding | IPI PMID:8844841 A novel complex of a phenolic derivative with insulin: struc... | ACCEPT | Summary: Structural study of insulin complexes related to TβR transition. Reason: Documents functional insulin oligomerization relevant to hexamer formation. Supporting Evidence: PMID:8844841 A novel complex of a phenolic derivative with insulin: structural features related to the T-->R transition. |
| GO:0008286 insulin receptor signaling pathway | IDA PMID:8702995 Akt, a pleckstrin homology domain containing kinase, is acti... | ACCEPT | Summary: This study demonstrated that insulin activates Akt (PKB) kinase primarily through phosphorylation, establishing insulin's role in the PI3K/Akt signaling cascade. Reason: This is a core biological process annotation for insulin. Activation of the insulin receptor signaling pathway is the primary mechanism by which insulin exerts its effects on glucose homeostasis and metabolism. Well-supported by extensive literature. Supporting Evidence: file:human/INS/INS-deep-research-perplexity.md The binding of insulin to its extracellular receptor leads to rapid and sequential autophosphorylation of multiple tyrosine residues distributed across different domains of the intracellular region file:human/INS/INS-deep-research-perplexity.md The phosphatidylinositol 3-kinase (PI3K) pathway represents the primary route through which insulin exerts its metabolic effects PMID:8702995 Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. file:human/INS/INS-deep-research-falcon.md **PI3KβPIP3βAKT** (metabolic branch): GLUT4 translocation, glycogen synthesis regulation via GSK3, mTOR-mediated protein synthesis, and transcriptional programs (e.g., FOXO regulation). |
| GO:0048018 receptor ligand activity | IDA PMID:8702995 Akt, a pleckstrin homology domain containing kinase, is acti... | ACCEPT | Summary: This is a general term indicating that insulin functions as a ligand for its receptor. This is accurate but less specific than "insulin receptor binding". Reason: This is a valid molecular function term that correctly describes insulin as a receptor ligand. While "insulin receptor binding" is more specific, both terms are appropriate and provide complementary information. Supporting Evidence: PMID:8702995 Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. |
| GO:0051897 positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | IDA PMID:8702995 Akt, a pleckstrin homology domain containing kinase, is acti... | ACCEPT | Summary: This annotation captures one of the two major signaling cascades activated by insulin - the PI3K/Akt pathway, which mediates most metabolic effects including glucose uptake, glycogen synthesis, and protein synthesis. Reason: This is a core signaling pathway for insulin and represents one of the most important mechanisms by which insulin regulates glucose homeostasis. Well-documented in the literature. Supporting Evidence: file:human/INS/INS-deep-research-perplexity.md The phosphatidylinositol 3-kinase (PI3K) pathway represents the primary route through which insulin exerts its metabolic effects, particularly regarding glucose homeostasis, glycogen synthesis, and protein synthesis file:human/INS/INS-deep-research-perplexity.md Once activated, AKT phosphorylates numerous downstream substrates that collectively mediate the metabolic effects of insulin PMID:8702995 Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. file:human/INS/INS-deep-research-falcon.md **PI3KβPIP3βAKT** (metabolic branch): GLUT4 translocation, glycogen synthesis regulation via GSK3, mTOR-mediated protein synthesis, and transcriptional programs (e.g., FOXO regulation). |
| GO:0005179 hormone activity | NAS PMID:14986111 Impaired binding of insulin to erythrocyte membrane receptor... | ACCEPT | Summary: Another instance of the hormone activity annotation, this time with NAS evidence code. Reason: Duplicate of earlier annotations but with different evidence. This is acceptable. Supporting Evidence: PMID:14986111 Impaired binding of insulin to erythrocyte membrane receptor and the activation of nitric oxide synthase by the hormone in human breast cancer. |
| GO:0005615 extracellular space | IDA PMID:9667398 Familial hyperproinsulinaemia due to a mutation substituting... | ACCEPT | Summary: Direct experimental evidence for insulin localization in extracellular space. Reason: This provides experimental (IDA) evidence for the cellular component annotation, complementing the IBA annotation. Supporting Evidence: PMID:9667398 Familial hyperproinsulinaemia due to a mutation substituting histidine for arginine at position 65 in proinsulin: identification of the mutation by restriction enzyme mapping. |
| GO:0008286 insulin receptor signaling pathway | IDA PMID:15792832 Insulin and nitric oxide stimulates glucose transport in hum... | ACCEPT | Summary: Study on insulin and nitric oxide stimulation of glucose transport in human placenta. Reason: Multiple independent experimental confirmations of insulin's role in the insulin receptor signaling pathway are valuable and support the core annotation. Supporting Evidence: PMID:15792832 2005 Jan 27. Insulin and nitric oxide stimulates glucose transport in human placenta. |
| GO:0008286 insulin receptor signaling pathway | IGI PMID:19727662 Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory... | UNDECIDED | Summary: The GOA reference for this annotation is PMID:19727662, which is in fact a NAMPT/visfatin paper on vascular smooth muscle cells, not an insulin paper (verified during PR #764 round-2 review). The annotation itself (insulin β insulin receptor signaling pathway) is correct in principle but the cited evidence does not actually support it; cannot validate without a correct PMID. Reason: Original GOA reference (PMID:19727662) is misattributed β it is a NAMPT paper, not an insulin paper. Action retained as UNDECIDED until GOA supplies (or curator identifies) a correctly-attributed reference for IGI evidence of INS in insulin receptor signaling. Note: the broader insulin receptor signaling pathway annotation remains amply supported elsewhere in this review by other valid references. Supporting Evidence: PMID:19727662 2009 Aug 29. Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity. |
| GO:0043123 positive regulation of canonical NF-kappaB signal transduction | IDA PMID:19727662 Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory... | UNDECIDED | Summary: The GOA reference for this annotation is PMID:19727662, which is in fact a NAMPT/visfatin paper, not an insulin paper (verified during PR #764 round-2 review). Cannot validate the IDA evidence for INS β NF-kappaB signaling on the cited reference alone. Reason: Original GOA reference (PMID:19727662) is misattributed β it is a NAMPT paper studying vascular smooth muscle cells, not an insulin paper. While insulin may activate NF-kappaB in some contexts, this specific annotation cannot be evaluated until a correct reference is supplied. Supporting Evidence: PMID:19727662 2009 Aug 29. Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity. |
| GO:0005179 hormone activity | IMP PMID:381941 A structurally abnormal insulin causing human diabetes. | ACCEPT | Summary: Classic study on structurally abnormal insulin causing diabetes, demonstrating hormone function. Reason: Another instance with experimental evidence (IMP) for hormone activity. Supporting Evidence: PMID:381941 A structurally abnormal insulin causing human diabetes. |
| GO:0008286 insulin receptor signaling pathway | IDA PMID:20455999 A novel domain of caveolin-2 that controls nuclear targeting... | ACCEPT | Summary: Study on caveolin-2 regulation of insulin-specific ERK activation. Reason: Additional experimental support for insulin receptor signaling pathway. Supporting Evidence: PMID:20455999 A novel domain of caveolin-2 that controls nuclear targeting: regulation of insulin-specific ERK activation and nuclear translocation by caveolin-2. |
| GO:0008286 insulin receptor signaling pathway | IMP PMID:14615391 Insulin stimulates glucose transport via nitric oxide/cyclic... | ACCEPT | Summary: Study showing insulin stimulates glucose transport via NO/cGMP pathway. Reason: Experimental evidence for insulin receptor signaling, though this highlights the NO/cGMP branch. Supporting Evidence: PMID:14615391 Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells. |
| GO:0000139 Golgi membrane | TAS Reactome:R-HSA-6809006 | ACCEPT | Summary: Proinsulin passes through the Golgi apparatus during its trafficking from ER to secretory granules. Reason: This is an accurate annotation for the biosynthetic trafficking of proinsulin through the secretory pathway. While not the final functional location, this represents an important intermediate location during insulin biogenesis in beta cells. Supporting Evidence: file:human/INS/INS-deep-research-falcon.md **Golgi/TGN:** trafficking and packaging into immature secretory granules. |
| GO:0000139 Golgi membrane | TAS Reactome:R-HSA-6809010 | ACCEPT | Summary: Duplicate Golgi membrane annotation from different Reactome reaction. Reason: Multiple Reactome reactions document proinsulin trafficking through Golgi. |
| GO:0000139 Golgi membrane | TAS Reactome:R-HSA-6809011 | ACCEPT | Summary: Another Golgi membrane annotation from Reactome. Reason: Additional Reactome support for Golgi localization. |
| GO:0005788 endoplasmic reticulum lumen | TAS Reactome:R-HSA-264997 | ACCEPT | Summary: Proinsulin enters the ER lumen after translocation and undergoes disulfide bond formation there. Reason: This is an accurate annotation for an early stage of insulin biosynthesis. Preproinsulin is translocated into the ER lumen where it is processed to proinsulin and undergoes critical folding and disulfide bond formation. Supporting Evidence: file:human/INS/INS-deep-research-perplexity.md Following translocation into the ER lumen, preproinsulin undergoes signal peptide cleavage to generate proinsulin, the 86-amino acid single-chain precursor of insulin file:human/INS/INS-deep-research-perplexity.md The ER environment is specifically optimized to facilitate this disulfide bond formation through multiple specialized mechanisms PMID:40052150 Proinsulin foldability is optimized in the ER, an environment evolved to support the folding process and the formation of disulfide bonds while minimizing misfolding. PMID:38935435 Hyperoxidation of the ER delays proinsulin export and limits the proinsulin supply available for insulin granule formation. |
| GO:0005788 endoplasmic reticulum lumen | TAS Reactome:R-HSA-265010 | ACCEPT | Summary: Another ER lumen annotation from Reactome pathway. Reason: Additional Reactome support for ER localization. |
| GO:0005796 Golgi lumen | TAS Reactome:R-HSA-264976 | ACCEPT | Summary: Proinsulin travels through the Golgi lumen and binds zinc and calcium there. Reason: Accurate annotation for proinsulin trafficking. The Golgi lumen is where proinsulin binds zinc and calcium ions, which are important for subsequent crystal formation in secretory granules. |
| GO:0005796 Golgi lumen | TAS Reactome:R-HSA-265010 | ACCEPT | Summary: Duplicate Golgi lumen annotation. Reason: Multiple Reactome reactions support Golgi lumen localization. |
| GO:0005796 Golgi lumen | TAS Reactome:R-HSA-265153 | ACCEPT | Summary: Another Golgi lumen annotation. Reason: Additional Reactome support. |
| GO:0030133 transport vesicle | TAS Reactome:R-HSA-6807877 | ACCEPT | Summary: Proinsulin travels in transport vesicles from ER to Golgi and from Golgi to secretory granules. Reason: Accurate annotation for the vesicular transport stages of insulin biosynthesis. |
| GO:0030133 transport vesicle | TAS Reactome:R-HSA-6809003 | ACCEPT | Summary: Duplicate transport vesicle annotation. Reason: Multiple Reactome reactions document vesicular transport. |
| GO:0030133 transport vesicle | TAS Reactome:R-HSA-6809006 | ACCEPT | Summary: Another transport vesicle annotation. Reason: Additional Reactome support. |
| GO:0033116 endoplasmic reticulum-Golgi intermediate compartment membrane | TAS Reactome:R-HSA-6807875 | ACCEPT | Summary: The ERGIC is an intermediate compartment between ER and Golgi that proinsulin passes through. Reason: This is an accurate annotation for the trafficking pathway. Proinsulin passes through the ERGIC compartment during its journey from ER to Golgi. |
| GO:0033116 endoplasmic reticulum-Golgi intermediate compartment membrane | TAS Reactome:R-HSA-6807877 | ACCEPT | Summary: Duplicate ERGIC annotation. Reason: Multiple Reactome reactions support ERGIC localization. |
| GO:0034774 secretory granule lumen | TAS Reactome:R-HSA-265153 | ACCEPT | Summary: Proinsulin is packaged into secretory granules where it is processed to mature insulin and stored as zinc-insulin crystals. Reason: This is a critical location for insulin. Secretory granules are where proinsulin is processed by prohormone convertases to mature insulin, and where insulin is stored as zinc-stabilized hexamers before secretion. This is an essential annotation. Supporting Evidence: file:human/INS/INS-deep-research-perplexity.md The PC1/3-mediated cleavage occurs within specialized secretory granules where pH is maintained at 5.0-5.5 by an intrinsic proton pump, creating conditions optimal for both prohormone processing and zinc-insulin crystal formation file:human/INS/INS-deep-research-perplexity.md These zinc-insulin hexamers represent the predominant storage form of insulin within pancreatic beta cell secretory granules, where they exist as water-insoluble crystals PMID:37159024 proinsulin is an early driver of insulin SG biogenesis, in a process in which its co-condensation with RESP18HD participates in their phase separation from other secretory proteins in transit through the same compartments but destined to other routes. file:human/INS/INS-deep-research-falcon.md **Immature/maturing secretory granules:** proteolytic conversion of proinsulin β insulin + C-peptide; granule acidification/condensation and storage. |
| GO:0034774 secretory granule lumen | TAS Reactome:R-NUL-9023165 | ACCEPT | Summary: Annotation for proinsulin processing in secretory granules (rat PC1/3 cleaves human proinsulin). Reason: Documents location where proinsulin processing occurs. |
| GO:0034774 secretory granule lumen | TAS Reactome:R-NUL-9023166 | ACCEPT | Summary: Another secretory granule annotation for processing steps. Reason: Additional Reactome support for secretory granule localization. |
| GO:0034774 secretory granule lumen | TAS Reactome:R-NUL-9023180 | ACCEPT | Summary: Secretory granule annotation for PC2-mediated cleavage step. Reason: Documents processing location. |
| GO:0034774 secretory granule lumen | TAS Reactome:R-NUL-9023186 | ACCEPT | Summary: Secretory granule annotation for carboxypeptidase processing. Reason: Additional Reactome support. |
| GO:0010976 positive regulation of neuron projection development | IC PMID:36250347 Insulin stimulates atypical protein kinase C-mediated phosph... | KEEP AS NON CORE | Summary: Study showing insulin stimulates neurite outgrowth through activation of atypical PKC and ARF6-Rac1 signaling. Reason: While insulin does have effects on neuronal development and function, this is not a primary core function. The core functions are metabolic regulation. Neuronal effects, while important, are secondary to the primary metabolic role. Supporting Evidence: PMID:36250347 Insulin stimulates atypical protein kinase C-mediated phosphorylation of the neuronal adaptor FE65 to potentiate neurite outgrowth by activating ARF6-Rac1 signaling. |
| GO:0048018 receptor ligand activity | IDA PMID:29512653 Structure of the insulin receptor-insulin complex by single-... | ACCEPT | Summary: Duplicate of earlier receptor ligand activity annotation with different reference. Reason: Multiple independent confirmations of receptor ligand activity are valuable. Supporting Evidence: PMID:29512653 Structure of the insulin receptor-insulin complex by single-particle cryo-EM analysis. |
| GO:0010629 negative regulation of gene expression | IDA PMID:31501273 MicroRNA 7 Impairs Insulin Signaling and Regulates AΞ² Levels... | KEEP AS NON CORE | Summary: This study showed insulin's involvement in regulating gene expression, particularly through microRNA-mediated mechanisms affecting IRS2, INSR, IDE, and LXR pathway. Reason: While insulin does regulate gene expression (e.g., suppression of gluconeogenic genes via FoxO1 inhibition), "negative regulation of gene expression" is very broad and non-specific. More specific terms like "negative regulation of gluconeogenesis" would be more informative. This should be kept but marked as non-core due to lack of specificity. Supporting Evidence: PMID:31501273 2019 Nov 15. MicroRNA 7 Impairs Insulin Signaling and Regulates AΞ² Levels through Posttranscriptional Regulation of the Insulin Receptor Substrate 2, Insulin Receptor, Insulin-Degrading Enzyme, and Liver X Receptor Pathway. |
| GO:0051897 positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | IDA PMID:25240198 Saturated fatty acid-induced miR-195 impairs insulin signali... | ACCEPT | Summary: Another confirmation of PI3K/Akt pathway activation by insulin. Reason: Additional experimental support for this core signaling pathway. Supporting Evidence: PMID:25240198 Epub 2014 Sep 19. Saturated fatty acid-induced miR-195 impairs insulin signaling and glycogen metabolism in HepG2 cells. |
| GO:0038060 nitric oxide-cGMP-mediated signaling | IDA PMID:14744991 Insulin induces the release of vasodilator compounds from pl... | KEEP AS NON CORE | Summary: Insulin induces vasodilation through NO-cGMP pathway, involving release of vasodilator compounds from platelets. Reason: While insulin does activate NO-cGMP signaling particularly in vascular endothelium, this is a secondary effect related to insulin's vascular actions. Not a core metabolic function, though physiologically important for blood flow regulation. Supporting Evidence: PMID:14744991 Insulin induces the release of vasodilator compounds from platelets by a nitric oxide-G kinase-VAMP-3-dependent pathway. |
| GO:0042311 vasodilation | IDA PMID:14744991 Insulin induces the release of vasodilator compounds from pl... | KEEP AS NON CORE | Summary: Insulin causes vasodilation through nitric oxide release. Reason: Vasodilation is a physiologically important effect of insulin but not a core function. The core function is metabolic regulation. Vascular effects, while significant, are peripheral to the primary role. Supporting Evidence: PMID:14744991 Insulin induces the release of vasodilator compounds from platelets by a nitric oxide-G kinase-VAMP-3-dependent pathway. |
| GO:0042311 vasodilation | NAS PMID:12946932 Insulin impairs endothelium-dependent vasodilation independe... | KEEP AS NON CORE | Summary: Additional evidence for insulin's vasodilatory effects. Reason: Duplicate of previous vasodilation annotation with different evidence. Supporting Evidence: PMID:12946932 Insulin impairs endothelium-dependent vasodilation independent of insulin sensitivity or lipid profile. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-110011 | ACCEPT | Summary: Multiple Reactome pathways document insulin in extracellular region during receptor binding and signaling. Reason: This broader term complements the more specific "extracellular space" annotation. Multiple Reactome reactions support this. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-74707 | ACCEPT | Summary: Reactome annotation for insulin binding to insulin receptor. Reason: Additional Reactome support for extracellular localization. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-74711 | ACCEPT | Summary: Reactome pathway annotation for extracellular region. Reason: Additional Reactome support. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-74712 | ACCEPT | Summary: Reactome pathway annotation. Reason: Additional Reactome support. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-74715 | ACCEPT | Summary: Reactome pathway annotation. Reason: Additional Reactome support. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-74716 | ACCEPT | Summary: Reactome pathway annotation. Reason: Additional Reactome support. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-74718 | ACCEPT | Summary: Reactome pathway annotation. Reason: Additional Reactome support. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-74740 | ACCEPT | Summary: Reactome pathway annotation. Reason: Additional Reactome support. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-74742 | ACCEPT | Summary: Reactome pathway annotation. Reason: Additional Reactome support. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-74743 | ACCEPT | Summary: Reactome pathway annotation. Reason: Additional Reactome support. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-976734 | ACCEPT | Summary: Reactome pathway annotation. Reason: Additional Reactome support. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-977136 | ACCEPT | Summary: Reactome pathway annotation. Reason: Additional Reactome support. |
| GO:0010750 positive regulation of nitric oxide mediated signal transduction | IDA PMID:15792832 Insulin and nitric oxide stimulates glucose transport in hum... | KEEP AS NON CORE | Summary: Insulin positively regulates NO-mediated signaling in placenta and vascular tissue. Reason: While insulin does regulate NO signaling, this is a secondary vascular/endothelial effect rather than a core metabolic function. Should be retained but marked as non-core. Supporting Evidence: PMID:15792832 2005 Jan 27. Insulin and nitric oxide stimulates glucose transport in human placenta. |
| GO:0046326 positive regulation of D-glucose import across plasma membrane | IDA PMID:15792832 Insulin and nitric oxide stimulates glucose transport in hum... | ACCEPT | Summary: This is one of THE core functions of insulin - stimulation of glucose uptake through GLUT4 translocation to the plasma membrane in muscle and adipose tissue. Reason: This is a core function annotation that captures one of the most important physiological actions of insulin - stimulation of glucose uptake. This is essential for glucose homeostasis. Supporting Evidence: file:human/INS/INS-deep-research-perplexity.md The most physiologically important function of insulin is the stimulation of glucose uptake from the bloodstream into insulin-responsive tissues, particularly skeletal muscle and adipose tissue, which together account for the majority of postprandial glucose disposal file:human/INS/INS-deep-research-perplexity.md Upon insulin stimulation, GLUT4-containing vesicles rapidly translocate to the plasma membrane, increasing cell surface GLUT4 by 2-3 fold and dramatically enhancing glucose transport capacity PMID:15792832 2005 Jan 27. Insulin and nitric oxide stimulates glucose transport in human placenta. |
| GO:0008284 positive regulation of cell population proliferation | IDA PMID:7688386 Insulin and IGF-1 increase mitogenesis and glucose metabolis... | KEEP AS NON CORE | Summary: Insulin and IGF-1 increase mitogenesis in multiple myeloma cell line. Insulin has mitogenic effects through MAPK/ERK pathway activation. Reason: While insulin does have growth-promoting and mitogenic effects, particularly through the MAPK pathway, this is not the core primary function. The primary function is metabolic regulation. Mitogenic effects are secondary, though physiologically important. Supporting Evidence: PMID:7688386 Insulin and IGF-1 increase mitogenesis and glucose metabolism in the multiple myeloma cell line, RPMI 8226. |
| GO:0010750 positive regulation of nitric oxide mediated signal transduction | IMP PMID:14615391 Insulin stimulates glucose transport via nitric oxide/cyclic... | KEEP AS NON CORE | Summary: Duplicate of earlier NO signaling annotation with different evidence code. Reason: Same as earlier - vascular effect, not core metabolic function. Supporting Evidence: PMID:14615391 Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells. |
| GO:1902952 positive regulation of dendritic spine maintenance | IGI PMID:19188609 Protection of synapses against Alzheimer's-linked toxins: in... | KEEP AS NON CORE | Summary: Insulin signaling protects synapses against Alzheimer's-related toxins and promotes dendritic spine maintenance. Reason: Neuronal/synaptic effects of insulin, while important for brain function and potentially relevant to neurodegenerative disease, are not core metabolic functions. This is a peripheral but interesting function. Supporting Evidence: PMID:19188609 Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. |
| GO:1903076 regulation of protein localization to plasma membrane | IGI PMID:19188609 Protection of synapses against Alzheimer's-linked toxins: in... | ACCEPT | Summary: This likely refers to insulin's effect on GLUT4 translocation and other membrane protein trafficking events. Reason: This is mechanistically related to insulin's core function of stimulating glucose uptake. The regulation of GLUT4 localization to plasma membrane is a key mechanism of insulin action. While broad, this annotation captures an important aspect of insulin signaling. Supporting Evidence: PMID:19188609 Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. |
| GO:1903427 negative regulation of reactive oxygen species biosynthetic process | IGI PMID:19188609 Protection of synapses against Alzheimer's-linked toxins: in... | KEEP AS NON CORE | Summary: Insulin has antioxidant effects and can suppress ROS production. Reason: While insulin does have antioxidant and protective effects, this is not a core function. This represents a peripheral effect related to cellular protection. Supporting Evidence: PMID:19188609 Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. |
| GO:1990535 neuron projection maintenance | IGI PMID:19188609 Protection of synapses against Alzheimer's-linked toxins: in... | KEEP AS NON CORE | Summary: Insulin signaling supports maintenance of neuronal projections. Reason: Neuronal effect, not core metabolic function. Supporting Evidence: PMID:19188609 Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. |
| GO:1900273 positive regulation of long-term synaptic potentiation | TAS PMID:19188609 Protection of synapses against Alzheimer's-linked toxins: in... | KEEP AS NON CORE | Summary: Insulin enhances synaptic plasticity and long-term potentiation in hippocampus. Reason: Neuronal/cognitive effect, not core metabolic function. Supporting Evidence: PMID:19188609 Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. |
| GO:0048167 regulation of synaptic plasticity | TAS PMID:19188609 Protection of synapses against Alzheimer's-linked toxins: in... | KEEP AS NON CORE | Summary: Insulin regulates synaptic plasticity. Reason: Neuronal effect, not core metabolic function. Supporting Evidence: PMID:19188609 Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. |
| GO:0050890 cognition | TAS PMID:19188609 Protection of synapses against Alzheimer's-linked toxins: in... | KEEP AS NON CORE | Summary: Insulin has roles in cognitive function. Reason: This is an extremely broad term. While insulin does affect cognition, this annotation is not specific or informative about insulin's actual function. Should be kept as non-core but is borderline over-annotation. Supporting Evidence: PMID:19188609 Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. |
| GO:0010628 positive regulation of gene expression | IGI PMID:25403480 Glucose tolerance is associated with differential expression... | KEEP AS NON CORE | Summary: Insulin regulates gene expression through various mechanisms including effects on transcription factors and microRNAs. Reason: While insulin does regulate gene expression (e.g., lipogenic genes via SREBP-1c, suppression of gluconeogenic genes), this term is extremely broad and non-specific. More specific terms about particular pathways would be more informative. Supporting Evidence: PMID:25403480 Nov 19. Glucose tolerance is associated with differential expression of microRNAs in skeletal muscle: results from studies of twins with and without type 2 diabetes. |
| GO:0043410 positive regulation of MAPK cascade | IDA PMID:20455999 A novel domain of caveolin-2 that controls nuclear targeting... | ACCEPT | Summary: Insulin activates the MAPK/ERK cascade through SHC-Grb2-SOS-Ras-Raf-MEK-ERK pathway. This is one of the two major signaling cascades activated by insulin receptor. Reason: The MAPK pathway is one of the two major signaling cascades downstream of insulin receptor (along with PI3K/Akt). While it plays a more prominent role in growth/proliferation than acute metabolic effects, it is still a core signaling pathway for insulin. Supporting Evidence: file:human/INS/INS-deep-research-perplexity.md In parallel with the PI3K/AKT pathway, insulin also activates the mitogen-activated protein kinase (MAPK) pathway primarily through interaction of the SHC adaptor protein with the phosphorylated insulin receptor file:human/INS/INS-deep-research-perplexity.md The MAPK pathway mediated by ERK1/2 has distinct biological effects compared to the PI3K/AKT pathway, with the MAPK pathway playing a more prominent role in the regulation of gene expression and cell proliferation PMID:20455999 A novel domain of caveolin-2 that controls nuclear targeting: regulation of insulin-specific ERK activation and nuclear translocation by caveolin-2. |
| GO:1900182 positive regulation of protein localization to nucleus | IDA PMID:20455999 A novel domain of caveolin-2 that controls nuclear targeting... | KEEP AS NON CORE | Summary: Study on caveolin-2 regulation of insulin-specific ERK activation and nuclear translocation. Reason: While insulin signaling does regulate nuclear translocation of various proteins (e.g., ERK, FoxO1), this is a very broad and non-specific annotation. It's mechanistically accurate but not informative about insulin's core functions. Supporting Evidence: PMID:20455999 A novel domain of caveolin-2 that controls nuclear targeting: regulation of insulin-specific ERK activation and nuclear translocation by caveolin-2. |
| GO:0050995 negative regulation of lipid catabolic process | IMP PMID:24675707 Resistin in dairy cows: plasma concentrations during early l... | ACCEPT | Summary: Insulin potently inhibits lipolysis in adipose tissue through inactivation of hormone-sensitive lipase. This is a core metabolic function and is amply supported by the deep research findings. However, the GOA-cited reference (PMID:24675707) is a dairy cow resistin paper, not a human insulin IMP study (verified during PR #764 round-2 review). Action retained as ACCEPT on the basis of the deep-research-supported function, with the misattributed reference flagged for GOA correction. Reason: Inhibition of lipolysis is a core, textbook metabolic function of insulin (see deep research supporting_text below). The GOA reference PMID:24675707 is misattributed (dairy cow resistin paper) and does not support this IMP annotation; flagged for GOA-side correction but the underlying biology is sound. Supporting Evidence: file:human/INS/INS-deep-research-perplexity.md Reciprocally, insulin potently inhibits lipolysis in adipose tissue through inactivation of hormone-sensitive lipase (HSL) via a PKA-independent mechanism file:human/INS/INS-deep-research-perplexity.md The net result is decreased adipose tissue lipolysis and reduced circulating free fatty acid levels |
| GO:1902176 negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | NAS PMID:16604263 Neuroprotection of insulin against oxidative stress-induced ... | KEEP AS NON CORE | Summary: Insulin provides neuroprotection against oxidative stress-induced apoptosis through PI3K/Akt pathway. Reason: While insulin does have anti-apoptotic and neuroprotective effects, this is not a core metabolic function. This represents a protective/survival effect that is peripheral to the primary role. Supporting Evidence: PMID:16604263 Neuroprotection of insulin against oxidative stress-induced apoptosis in cultured retinal neurons: involvement of phosphoinositide 3-kinase/Akt signal pathway. |
| GO:0031904 endosome lumen | TAS Reactome:R-HSA-74718 | ACCEPT | Summary: After internalization of the insulin-insulin receptor complex, insulin traffics through endosomes where it can be degraded or the receptor recycled. Reason: This is an accurate annotation for insulin trafficking after receptor-mediated endocytosis. The endosomal pathway is important for both insulin degradation and receptor recycling. |
| GO:0031904 endosome lumen | TAS Reactome:R-HSA-74726 | ACCEPT | Summary: Reactome pathway for insulin in endosomes. Reason: Additional Reactome support for endosomal localization. |
| GO:0031904 endosome lumen | TAS Reactome:R-HSA-74730 | ACCEPT | Summary: Reactome pathway for insulin degradation in endosomes. Reason: Insulin is degraded in endosomes by insulin-degrading enzyme. |
| GO:0090277 positive regulation of peptide hormone secretion | TAS PMID:11387233 Insulin and glucocorticoids differentially regulate leptin t... | KEEP AS NON CORE | Summary: Insulin can regulate secretion of other peptide hormones like leptin. Reason: While insulin does affect secretion of other hormones, this is not a core function. The primary function is metabolic regulation through direct cellular effects, not through regulating other hormones (though that does occur). Supporting Evidence: PMID:11387233 Insulin and glucocorticoids differentially regulate leptin transcription and secretion in brown adipocytes. |
| GO:0090336 positive regulation of brown fat cell differentiation | TAS PMID:11387233 Insulin and glucocorticoids differentially regulate leptin t... | KEEP AS NON CORE | Summary: Insulin promotes brown adipocyte differentiation. Reason: While insulin does have effects on adipocyte differentiation, this is a developmental/ differentiation effect rather than a core acute metabolic function. Should be retained but marked as non-core. Supporting Evidence: PMID:11387233 Insulin and glucocorticoids differentially regulate leptin transcription and secretion in brown adipocytes. |
| GO:0002020 protease binding | IPI PMID:20082125 In vitro degradation of insulin-like peptide 3 by insulin-de... | ACCEPT | Summary: Insulin binds to insulin-degrading enzyme (IDE), a metalloprotease that degrades insulin. Reason: This is a more specific and informative term than generic "protein binding". Binding to IDE is functionally important for insulin clearance and degradation. This is an appropriate annotation. Supporting Evidence: PMID:20082125 In vitro degradation of insulin-like peptide 3 by insulin-degrading enzyme. |
| GO:0045840 positive regulation of mitotic nuclear division | IDA PMID:10644978 PSM, a mediator of PDGF-BB-, IGF-I-, and insulin-stimulated ... | KEEP AS NON CORE | Summary: Insulin stimulates mitosis through activation of mitogenic signaling pathways. Reason: Mitogenic effects are secondary to core metabolic functions, mediated primarily through MAPK pathway. Should be retained but as non-core. Supporting Evidence: PMID:10644978 PSM, a mediator of PDGF-BB-, IGF-I-, and insulin-stimulated mitogenesis. |
| GO:2000252 negative regulation of feeding behavior | IDA PMID:17957153 Milk intake and feeding behavior in the first week of life a... | KEEP AS NON CORE | Summary: Insulin acts in the brain to suppress appetite and reduce food intake. Reason: While insulin's central effects on appetite are physiologically important and contribute to overall energy homeostasis, this is not a direct metabolic function. It's a behavioral/ neurological effect that is peripheral to core function. Supporting Evidence: PMID:17957153 Milk intake and feeding behavior in the first week of life and its relationship to cord blood ghrelin, leptin, and insulin concentrations. |
| GO:0060267 positive regulation of respiratory burst | IDA PMID:9092559 Insulin-induced activation of NADPH-dependent H2O2 generatio... | KEEP AS NON CORE | Summary: Insulin can stimulate NADPH oxidase and ROS production in adipocytes. Reason: Respiratory burst regulation is an immune cell function. While insulin may affect ROS production in some contexts, this is not a core function and may represent a non-specific effect. Supporting Evidence: PMID:9092559 Insulin-induced activation of NADPH-dependent H2O2 generation in human adipocyte plasma membranes is mediated by Galphai2. |
| GO:0030335 positive regulation of cell migration | ISS PMID:12138094 Insulin/insulin-like growth factor I hybrid receptors have d... | KEEP AS NON CORE | Summary: Insulin can promote cell migration. Reason: Cell migration effects are not core metabolic functions. This is a peripheral cellular effect. Supporting Evidence: PMID:12138094 2002 Jul 22. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. |
| GO:0043410 positive regulation of MAPK cascade | IDA PMID:11500939 Regulation of the Akt/Glycogen synthase kinase-3 axis by ins... | ACCEPT | Summary: Duplicate of earlier MAPK annotation with different reference. Reason: Additional experimental support for core MAPK pathway activation. Supporting Evidence: PMID:11500939 Regulation of the Akt/Glycogen synthase kinase-3 axis by insulin-like growth factor-II via activation of the human insulin receptor isoform-A. |
| GO:0045840 positive regulation of mitotic nuclear division | IDA PMID:11500939 Regulation of the Akt/Glycogen synthase kinase-3 axis by ins... | KEEP AS NON CORE | Summary: Duplicate mitosis annotation. Reason: Same as earlier - mitogenic effect, not core function. Supporting Evidence: PMID:11500939 Regulation of the Akt/Glycogen synthase kinase-3 axis by insulin-like growth factor-II via activation of the human insulin receptor isoform-A. |
| GO:0051897 positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | IDA PMID:11500939 Regulation of the Akt/Glycogen synthase kinase-3 axis by ins... | ACCEPT | Summary: Another confirmation of PI3K/Akt pathway. Reason: Additional support for core PI3K/Akt signaling. Supporting Evidence: PMID:11500939 Regulation of the Akt/Glycogen synthase kinase-3 axis by insulin-like growth factor-II via activation of the human insulin receptor isoform-A. |
| GO:0051897 positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | IDA PMID:7688386 Insulin and IGF-1 increase mitogenesis and glucose metabolis... | ACCEPT | Summary: Another PI3K/Akt confirmation. Reason: Additional support for core pathway. Supporting Evidence: PMID:7688386 Insulin and IGF-1 increase mitogenesis and glucose metabolism in the multiple myeloma cell line, RPMI 8226. |
| GO:0008284 positive regulation of cell population proliferation | IDA PMID:17925406 Activation of the insulin receptor by insulin and a syntheti... | KEEP AS NON CORE | Summary: Duplicate proliferation annotation. Reason: Mitogenic effect, not core metabolic function. Supporting Evidence: PMID:17925406 2007 Oct 9. Activation of the insulin receptor by insulin and a synthetic peptide leads to divergent metabolic and mitogenic signaling and responses. |
| GO:0045725 positive regulation of glycogen biosynthetic process | IDA PMID:17925406 Activation of the insulin receptor by insulin and a syntheti... | ACCEPT | Summary: Insulin stimulates glycogen synthesis through activation of glycogen synthase. This is a core metabolic function. Reason: Glycogen synthesis is a core metabolic function of insulin. In the fed state, insulin promotes storage of glucose as glycogen in liver and muscle, which is essential for glucose homeostasis. Supporting Evidence: file:human/INS/INS-deep-research-perplexity.md Simultaneously, insulin activates glycogen synthase through PP1-mediated dephosphorylation, promoting the synthesis of new glycogen from glucose-6-phosphate file:human/INS/INS-uniprot.txt It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. PMID:17925406 2007 Oct 9. Activation of the insulin receptor by insulin and a synthetic peptide leads to divergent metabolic and mitogenic signaling and responses. |
| GO:0030307 positive regulation of cell growth | NAS PMID:11742412 Insulin signalling and the regulation of glucose and lipid m... | KEEP AS NON CORE | Summary: Insulin promotes cell growth through activation of protein synthesis and suppression of protein degradation. Reason: While insulin does promote cell growth, this is secondary to its core metabolic functions. Growth-promoting effects are mediated through mTOR pathway and protein synthesis machinery. Supporting Evidence: PMID:11742412 Insulin signalling and the regulation of glucose and lipid metabolism. |
| GO:0045597 positive regulation of cell differentiation | NAS PMID:11742412 Insulin signalling and the regulation of glucose and lipid m... | KEEP AS NON CORE | Summary: Insulin affects differentiation of various cell types including adipocytes. Reason: Differentiation effects are developmental rather than acute metabolic functions. Non-core. Supporting Evidence: PMID:11742412 Insulin signalling and the regulation of glucose and lipid metabolism. |
| GO:0045721 negative regulation of gluconeogenesis | NAS PMID:11742412 Insulin signalling and the regulation of glucose and lipid m... | ACCEPT | Summary: Insulin suppresses hepatic gluconeogenesis through inhibition of FoxO1 and CREB transcription factors, reducing expression of PEPCK and G6Pase. This is a core metabolic function. Reason: Suppression of hepatic gluconeogenesis is a core function of insulin, essential for preventing excessive glucose production by the liver in the fed state. This is critical for glucose homeostasis. Supporting Evidence: file:human/INS/INS-deep-research-perplexity.md The suppression of hepatic gluconeogenesis by insulin involves inhibition of the transcription factors CREB and FoxO1, which normally activate the expression of the rate-limiting gluconeogenic enzymes phosphoenolpyruvate carboxylase (PEPCK) and glucose-6-phosphatase file:human/INS/INS-deep-research-perplexity.md The AKT-mediated phosphorylation and inactivation of FoxO1, combined with reduced CREB activity following insulin treatment, leads to decreased expression of gluconeogenic enzymes and reduced hepatic glucose production PMID:11742412 Insulin signalling and the regulation of glucose and lipid metabolism. |
| GO:0046889 positive regulation of lipid biosynthetic process | NAS PMID:11742412 Insulin signalling and the regulation of glucose and lipid m... | ACCEPT | Summary: Insulin stimulates lipogenesis through activation of SREBP-1c and lipogenic enzymes including fatty acid synthase and acetyl-CoA carboxylase. This is a core metabolic function. Reason: Lipogenesis is a core metabolic function of insulin. In the fed state, insulin promotes synthesis of fatty acids and triglycerides for energy storage, which is essential for energy homeostasis. Supporting Evidence: file:human/INS/INS-deep-research-perplexity.md Insulin is a potent anabolic hormone that stimulates fatty acid synthesis and triglyceride storage in adipose tissue and liver through multiple transcriptional and post-translational mechanisms file:human/INS/INS-deep-research-perplexity.md Upon insulin stimulation, SREBP-1c undergoes proteolytic activation in the Golgi apparatus, releasing the transcriptionally active N-terminal fragment that translocates to the nucleus and activates transcription of genes encoding enzymes required for fatty acid synthesis PMID:11742412 Insulin signalling and the regulation of glucose and lipid metabolism. |
| GO:0050995 negative regulation of lipid catabolic process | NAS PMID:11742412 Insulin signalling and the regulation of glucose and lipid m... | ACCEPT | Summary: Duplicate of earlier lipolysis inhibition annotation. Reason: Core metabolic function - inhibition of lipolysis. Supporting Evidence: PMID:11742412 Insulin signalling and the regulation of glucose and lipid metabolism. |
| GO:0060266 negative regulation of respiratory burst involved in inflammatory response | IDA PMID:11443198 Insulin inhibits intranuclear nuclear factor kappaB and stim... | KEEP AS NON CORE | Summary: Insulin has anti-inflammatory effects including suppression of inflammatory ROS production. Reason: Anti-inflammatory effects are not core metabolic functions. These are peripheral effects. Supporting Evidence: PMID:11443198 Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? Dandona P(1), Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, Ahmad S. |
| GO:0045821 positive regulation of glycolytic process | IMP PMID:381941 A structurally abnormal insulin causing human diabetes. | ACCEPT | Summary: Insulin stimulates glycolysis by increasing glucose uptake and promoting glycolytic enzyme activity. Reason: Stimulation of glycolysis is a core metabolic function of insulin. Insulin promotes glucose utilization through glycolysis, which is part of its overall role in glucose homeostasis. Supporting Evidence: file:human/INS/INS-uniprot.txt It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. PMID:381941 A structurally abnormal insulin causing human diabetes. |
| GO:0006355 regulation of DNA-templated transcription | NAS PMID:12881524 Differential gene expression induced by insulin and insulin-... | KEEP AS NON CORE | Summary: Insulin regulates transcription of many genes. Reason: This is an extremely broad and non-specific term. While insulin does regulate transcription (e.g., lipogenic genes, gluconeogenic genes), this annotation is too general to be informative. More specific terms about particular genes or pathways would be better. Supporting Evidence: PMID:12881524 2003 Jul 24. Differential gene expression induced by insulin and insulin-like growth factor-II through the insulin receptor isoform A. |
| GO:0007186 G protein-coupled receptor signaling pathway | IDA PMID:9092559 Insulin-induced activation of NADPH-dependent H2O2 generatio... | KEEP AS NON CORE | Summary: Study showing insulin-induced NADPH-dependent H2O2 generation is mediated by GΞ±i2, suggesting crosstalk with GPCR pathways. Reason: While there may be some crosstalk between insulin signaling and GPCR pathways, insulin itself signals through a receptor tyrosine kinase, not a GPCR. This annotation may represent indirect effects or experimental artifacts. Should be kept but as non-core with skepticism. Supporting Evidence: PMID:9092559 Insulin-induced activation of NADPH-dependent H2O2 generation in human adipocyte plasma membranes is mediated by Galphai2. |
| GO:0006953 acute-phase response | IDA PMID:14739855 Insulin decreases hepatic acute phase protein levels in seve... | KEEP AS NON CORE | Summary: Insulin decreases hepatic acute phase protein levels. Reason: Effects on acute phase response are not core metabolic functions. This is a peripheral effect related to inflammation/stress responses. Supporting Evidence: PMID:14739855 Insulin decreases hepatic acute phase protein levels in severely burned children. |
| GO:0032880 regulation of protein localization | IDA PMID:14615391 Insulin stimulates glucose transport via nitric oxide/cyclic... | ACCEPT | Summary: Very broad term covering insulin's effects on protein trafficking including GLUT4 translocation. Reason: While this is a broad term, it does capture important mechanisms like GLUT4 translocation which are central to insulin action. The term is accurate even if not maximally specific. Supporting Evidence: PMID:14615391 Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells. |
| GO:0042060 wound healing | IDA PMID:9498508 Effects of insulin on wound healing. | KEEP AS NON CORE | Summary: Insulin has effects on wound healing processes. Reason: Wound healing effects are not core metabolic functions. These are peripheral tissue repair effects. Supporting Evidence: PMID:9498508 Effects of insulin on wound healing. |
| GO:0046326 positive regulation of D-glucose import across plasma membrane | IDA PMID:14615391 Insulin stimulates glucose transport via nitric oxide/cyclic... | ACCEPT | Summary: Duplicate glucose uptake annotation. Reason: Core function - additional experimental support. Supporting Evidence: PMID:14615391 Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells. |
| GO:0050709 negative regulation of protein secretion | IDA PMID:14739855 Insulin decreases hepatic acute phase protein levels in seve... | KEEP AS NON CORE | Summary: Insulin can suppress secretion of certain proteins like acute phase proteins. Reason: Effects on protein secretion are not core functions. This is a peripheral effect. Supporting Evidence: PMID:14739855 Insulin decreases hepatic acute phase protein levels in severely burned children. |
| GO:0055089 fatty acid homeostasis | IMP PMID:1184755 Glucagon regulation of plasma ketone body concentration in h... | ACCEPT | Summary: Insulin regulates fatty acid homeostasis through effects on lipogenesis, lipolysis, and fatty acid oxidation. Reason: Fatty acid homeostasis is a core metabolic function of insulin. Insulin regulates both synthesis and breakdown of fatty acids, which is integral to overall energy homeostasis. This is an appropriate high-level annotation. Supporting Evidence: PMID:1184755 Glucagon regulation of plasma ketone body concentration in human diabetes. |
| GO:0002674 negative regulation of acute inflammatory response | IDA PMID:11443198 Insulin inhibits intranuclear nuclear factor kappaB and stim... | KEEP AS NON CORE | Summary: Insulin has anti-inflammatory effects. Reason: Anti-inflammatory effects are not core metabolic functions. Supporting Evidence: PMID:11443198 Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? Dandona P(1), Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, Ahmad S. |
| GO:0005158 insulin receptor binding | IDA PMID:9667398 Familial hyperproinsulinaemia due to a mutation substituting... | ACCEPT | Summary: Direct experimental evidence for insulin receptor binding. Reason: Additional IDA support for the core molecular function. Supporting Evidence: PMID:9667398 Familial hyperproinsulinaemia due to a mutation substituting histidine for arginine at position 65 in proinsulin: identification of the mutation by restriction enzyme mapping. |
| GO:0005179 hormone activity | IC PMID:9667398 Familial hyperproinsulinaemia due to a mutation substituting... | ACCEPT | Summary: Another hormone activity annotation. Reason: Additional support for hormone activity. Supporting Evidence: PMID:9667398 Familial hyperproinsulinaemia due to a mutation substituting histidine for arginine at position 65 in proinsulin: identification of the mutation by restriction enzyme mapping. |
| GO:0042593 glucose homeostasis | IMP PMID:381941 A structurally abnormal insulin causing human diabetes. | ACCEPT | Summary: Study on structurally abnormal insulin causing diabetes demonstrates insulin's role in glucose homeostasis. Reason: Core function - genetic evidence from natural mutation. Supporting Evidence: PMID:381941 A structurally abnormal insulin causing human diabetes. |
| GO:0045818 negative regulation of glycogen catabolic process | IMP PMID:381941 A structurally abnormal insulin causing human diabetes. | ACCEPT | Summary: Insulin inhibits glycogenolysis (glycogen breakdown) in liver and muscle. Reason: Inhibition of glycogenolysis is a core function of insulin. In the fed state, insulin suppresses glycogen breakdown while promoting glycogen synthesis, which is essential for glucose homeostasis. Supporting Evidence: file:human/INS/INS-deep-research-perplexity.md Insulin rapidly inhibits hepatic glycogenolysis through mechanisms involving protein phosphatase-1 (PP1), which is activated through insulin-mediated suppression of glycogen phosphorylase kinase PMID:381941 A structurally abnormal insulin causing human diabetes. |
| GO:0045922 negative regulation of fatty acid metabolic process | IMP PMID:1184755 Glucagon regulation of plasma ketone body concentration in h... | ACCEPT | Summary: Insulin inhibits fatty acid oxidation and mobilization. Reason: Suppression of fatty acid oxidation and mobilization (lipolysis) is a core metabolic function. This complements the earlier annotation on inhibition of lipolysis. Supporting Evidence: PMID:1184755 Glucagon regulation of plasma ketone body concentration in human diabetes. |
| GO:0045821 positive regulation of glycolytic process | IDA PMID:7688386 Insulin and IGF-1 increase mitogenesis and glucose metabolis... | ACCEPT | Summary: Duplicate glycolysis annotation. Reason: Core function - additional experimental support. Supporting Evidence: PMID:7688386 Insulin and IGF-1 increase mitogenesis and glucose metabolism in the multiple myeloma cell line, RPMI 8226. |
| GO:0046628 positive regulation of insulin receptor signaling pathway | IDA PMID:7688386 Insulin and IGF-1 increase mitogenesis and glucose metabolis... | ACCEPT | Summary: Insulin positively regulates its own receptor signaling pathway by binding and activating the receptor. Reason: This is essentially describing insulin's primary mechanism of action. While it may seem redundant with "insulin receptor binding" and "insulin receptor signaling pathway", it correctly captures that insulin is the positive regulator of this pathway. Acceptable. Supporting Evidence: PMID:7688386 Insulin and IGF-1 increase mitogenesis and glucose metabolism in the multiple myeloma cell line, RPMI 8226. |
| GO:0005158 insulin receptor binding | IPI PMID:8452530 Purified hybrid insulin/insulin-like growth factor-I recepto... | ACCEPT | Summary: Another insulin receptor binding annotation. Reason: Additional experimental support for core molecular function. Supporting Evidence: PMID:8452530 Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. |
| GO:0005159 insulin-like growth factor receptor binding | IPI PMID:8452530 Purified hybrid insulin/insulin-like growth factor-I recepto... | KEEP AS NON CORE | Summary: Study on hybrid insulin/IGF-I receptors. Insulin can bind to IGF-I receptor with lower affinity than to insulin receptor. Reason: While insulin can bind to IGF-I receptors, particularly hybrid receptors, this is not the primary physiological binding partner. The insulin receptor is the specific high-affinity receptor. IGF-I receptor binding represents cross-reactivity rather than core function. Supporting Evidence: PMID:8452530 Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. |
| GO:0005158 insulin receptor binding | IDA PMID:7556975 Binding of human, porcine and bovine insulin to insulin rece... | ACCEPT | Summary: Another insulin receptor binding annotation. Reason: Additional support for core molecular function. Supporting Evidence: PMID:7556975 Binding of human, porcine and bovine insulin to insulin receptors from human brain, muscle and adipocytes and to expressed recombinant alternatively spliced insulin receptor isoforms. |
| GO:0005576 extracellular region | IC PMID:7556975 Binding of human, porcine and bovine insulin to insulin rece... | ACCEPT | Summary: Another extracellular region annotation. Reason: Additional support for extracellular localization. Supporting Evidence: PMID:7556975 Binding of human, porcine and bovine insulin to insulin receptors from human brain, muscle and adipocytes and to expressed recombinant alternatively spliced insulin receptor isoforms. |
| GO:0007267 cell-cell signaling | IC PMID:7556975 Binding of human, porcine and bovine insulin to insulin rece... | ACCEPT | Summary: Insulin functions as a cell-cell signaling molecule, being secreted from beta cells and signaling to distant target cells. Reason: This is an accurate high-level annotation. Insulin is a classic example of endocrine cell-cell signaling. While not maximally specific, this term correctly categorizes insulin's biological role. Supporting Evidence: PMID:7556975 Binding of human, porcine and bovine insulin to insulin receptors from human brain, muscle and adipocytes and to expressed recombinant alternatively spliced insulin receptor isoforms. |
| GO:0001819 positive regulation of cytokine production | IDA PMID:15473891 Insulin activates vascular endothelial growth factor in vasc... | KEEP AS NON CORE | Summary: Insulin can stimulate production of cytokines like VEGF. Reason: Effects on cytokine production are not core metabolic functions. This represents an immunological/inflammatory effect that is peripheral. Supporting Evidence: PMID:15473891 Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance. |
| GO:0042177 negative regulation of protein catabolic process | IDA PMID:15185208 Intravenous insulin decreases protein breakdown in infants o... | ACCEPT | Summary: Insulin suppresses protein degradation through inhibition of proteasome and autophagy pathways. Reason: Suppression of protein degradation is a core anabolic function of insulin. Along with stimulation of protein synthesis, inhibition of protein breakdown contributes to insulin's overall anabolic effects. Supporting Evidence: file:human/INS/INS-deep-research-perplexity.md Insulin is also a powerful regulator of protein turnover, stimulating protein synthesis while simultaneously inhibiting protein degradation, thereby promoting net protein anabolism file:human/INS/INS-deep-research-perplexity.md In contrast, insulin suppresses hepatic protein degradation through inhibition of the ATP-ubiquitin-dependent proteasome pathway and ATP-independent lysosomal proteases PMID:15185208 Intravenous insulin decreases protein breakdown in infants on extracorporeal membrane oxygenation. |
| GO:0046631 alpha-beta T cell activation | IDA PMID:10604997 Bovine and human insulin activate CD8+-autoreactive CTL expr... | KEEP AS NON CORE | Summary: Study showing insulin can activate T cells. Reason: T cell activation is an immunological function, not a core metabolic function. This is a peripheral effect and may even be pathological in the context of type 1 diabetes where insulin can serve as an autoantigen. Supporting Evidence: PMID:10604997 Bovine and human insulin activate CD8+-autoreactive CTL expressing both type 1 and type 2 cytokines in C57BL/6 mice. |
| GO:0050708 regulation of protein secretion | IDA PMID:15591776 Insulin decreases the secretion of apoB-100 from hepatic Hep... | KEEP AS NON CORE | Summary: Insulin regulates secretion of various proteins including apolipoproteins. Reason: While insulin does affect protein secretion in some contexts (e.g., apolipoprotein secretion from hepatocytes), this is not a core function. More specific terms about lipid metabolism would be more appropriate. Supporting Evidence: PMID:15591776 Insulin decreases the secretion of apoB-100 from hepatic HepG2 cells but does not decrease the secretion of apoB-48 from intestinal CaCo-2 cells. |
| GO:0051000 positive regulation of nitric-oxide synthase activity | NAS PMID:12135947 Insulin-dependent activation of endothelial nitric oxide syn... | KEEP AS NON CORE | Summary: Insulin activates endothelial nitric oxide synthase (eNOS). Reason: NO synthase activation is a vascular endothelial effect, not a core metabolic function. This is related to insulin's vascular actions. Supporting Evidence: PMID:12135947 Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. |
| GO:1904659 D-glucose transmembrane transport | NAS | NEW | Summary: Added to align core_functions with existing annotations. Reason: Core function term not present in existing_annotations. Supporting Evidence: file:human/INS/INS-deep-research-perplexity.md The most physiologically important function of insulin is the stimulation of glucose uptake from the bloodstream into insulin-responsive tissues, particularly skeletal muscle and adipose tissue, which together account for the majority of postprandial glucose disposal. This metabolic action is mediated through the insulin-dependent translocation of glucose transporter type-4 (GLUT4) from intracellular membrane compartments to the plasma membrane file:human/INS/INS-deep-research-perplexity.md Following AKT activation, the serine/threonine kinase AS160 (also known as TBC1D4) is phosphorylated by AKT, leading to its release from GLUT4-containing storage vesicles. This phosphorylation event activates the RabGAP activity of AS160, converting Rab small GTPases to their inactive GDP-bound state and enabling GLUT4 vesicle mobilization |
| GO:0008610 lipid biosynthetic process | NAS | NEW | Summary: Added to align core_functions with existing annotations. Reason: Core function term not present in existing_annotations. Supporting Evidence: file:human/INS/INS-deep-research-perplexity.md Insulin is a potent anabolic hormone that stimulates fatty acid synthesis and triglyceride storage in adipose tissue and liver through multiple transcriptional and post-translational mechanisms. The key transcription factors mediating insulin-induced lipogenic gene expression are the sterol regulatory element binding proteins (SREBPs), particularly SREBP-1c in lipogenic tissues file:human/INS/INS-deep-research-perplexity.md Reciprocally, insulin potently inhibits lipolysis in adipose tissue through inactivation of hormone-sensitive lipase (HSL) via a PKA-independent mechanism. Insulin-activated AKT phosphorylates and inactivates phosphodiesterase 3B (PDE3B), reducing the degradation of cAMP and preventing PKA activation |
| GO:0045542 positive regulation of cholesterol biosynthetic process | NAS | NEW | Summary: Added to align core_functions with existing annotations. Reason: Core function term not present in existing_annotations. Supporting Evidence: file:human/INS/INS-deep-research-perplexity.md Insulin is a potent anabolic hormone that stimulates fatty acid synthesis and triglyceride storage in adipose tissue and liver through multiple transcriptional and post-translational mechanisms. The key transcription factors mediating insulin-induced lipogenic gene expression are the sterol regulatory element binding proteins (SREBPs), particularly SREBP-1c in lipogenic tissues file:human/INS/INS-deep-research-perplexity.md Reciprocally, insulin potently inhibits lipolysis in adipose tissue through inactivation of hormone-sensitive lipase (HSL) via a PKA-independent mechanism. Insulin-activated AKT phosphorylates and inactivates phosphodiesterase 3B (PDE3B), reducing the degradation of cAMP and preventing PKA activation |
| GO:0010906 regulation of glucose metabolic process | NAS | NEW | Summary: Added to align core_functions with existing annotations. Reason: Core function term not present in existing_annotations. Supporting Evidence: file:human/INS/INS-deep-research-perplexity.md Insulin is a potent anabolic hormone that stimulates fatty acid synthesis and triglyceride storage in adipose tissue and liver through multiple transcriptional and post-translational mechanisms. The key transcription factors mediating insulin-induced lipogenic gene expression are the sterol regulatory element binding proteins (SREBPs), particularly SREBP-1c in lipogenic tissues file:human/INS/INS-deep-research-perplexity.md Reciprocally, insulin potently inhibits lipolysis in adipose tissue through inactivation of hormone-sensitive lipase (HSL) via a PKA-independent mechanism. Insulin-activated AKT phosphorylates and inactivates phosphodiesterase 3B (PDE3B), reducing the degradation of cAMP and preventing PKA activation |
| GO:0045727 positive regulation of translation | NAS | NEW | Summary: Insulin does not perform translation itself β it positively regulates translation in target cells via the mTOR/S6K1/4E-BP1 axis. Per PR #764 review feedback, the previously proposed NEW GO:0006412 (translation) term has been replaced with GO:0045727 (positive regulation of translation), which correctly captures insulin's regulatory role. Reason: Insulin signaling positively regulates translation in target tissues; the protein itself does not perform translation. Supporting Evidence: file:human/INS/INS-deep-research-perplexity.md Insulin is also a powerful regulator of protein turnover, stimulating protein synthesis while simultaneously inhibiting protein degradation, thereby promoting net protein anabolism. Insulin stimulates protein synthesis through multiple mechanisms including increased cellular uptake of amino acids through upregulation of amino acid transporters, particularly for branched-chain amino acids (BCAAs) such as leucine file:human/INS/INS-deep-research-perplexity.md Following insulin stimulation and increased leucine availability, mTORC1 phosphorylates S6K1 and 4E-BP1, leading to translation initiation factor phosphorylation and enhanced translation of mRNA molecules, particularly those encoding protein synthesis machinery and growth-promoting proteins |
Loading supporting contentβ¦
Download this section (compressed HTML)Loading supporting contentβ¦
Download this section (compressed HTML)Loading supporting contentβ¦
Download this section (compressed HTML)Loading supporting contentβ¦
Download this section (compressed HTML)